A Randomized Controlled Study of Recombinant Anti-tumor and Anti-Virus Protein for Injection Compared With Placebo in Treating Patients With Metastatic Colorectal Cancer After Failure of Second-Line and Above Treatment.

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 28 Jan 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Novaferon (Primary)
Indications Colorectal cancer
Focus Therapeutic Use
Sponsors Genova Biotech Company

Most Recent Events

04 Jan 2016 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
04 Jan 2016 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
28 Jan 2014 According to the ClinicalTrials.gov record, blinding, number of arms,treatment details and number of patients are amended.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight